BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

925 related articles for article (PubMed ID: 33961783)

  • 1. Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer.
    Hornburg M; Desbois M; Lu S; Guan Y; Lo AA; Kaufman S; Elrod A; Lotstein A; DesRochers TM; Munoz-Rodriguez JL; Wang X; Giltnane J; Mayba O; Turley SJ; Bourgon R; Daemen A; Wang Y
    Cancer Cell; 2021 Jul; 39(7):928-944.e6. PubMed ID: 33961783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.
    Guo L; Cui ZM; Zhang J; Huang Y
    Chin J Cancer; 2011 May; 30(5):336-43. PubMed ID: 21527066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues.
    Nakayama T; Hieshima K; Izawa D; Tatsumi Y; Kanamaru A; Yoshie O
    J Immunol; 2003 Feb; 170(3):1136-40. PubMed ID: 12538668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXC chemokine ligand 16: a Swiss army knife chemokine in cancer.
    Gowhari Shabgah A; Qasim MT; Mojtaba Mostafavi S; Olegovna Zekiy A; Ezzatifar F; Ahmadi M; Mohammadian Haftcheshmeh S; Gholizadeh Navashenaq J
    Expert Rev Mol Med; 2021 Apr; 23():e4. PubMed ID: 33880989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue.
    Bradfield PF; Amft N; Vernon-Wilson E; Exley AE; Parsonage G; Rainger GE; Nash GB; Thomas AM; Simmons DL; Salmon M; Buckley CD
    Arthritis Rheum; 2003 Sep; 48(9):2472-82. PubMed ID: 13130466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity and intratumoral heterogeneity in human gallbladder cancer progression revealed by single-cell RNA sequencing.
    Chen P; Wang Y; Li J; Bo X; Wang J; Nan L; Wang C; Ba Q; Liu H; Wang H
    Clin Transl Med; 2021 Jun; 11(6):e462. PubMed ID: 34185421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context.
    Chia TY; Billingham LK; Boland L; Katz JL; Arrieta VA; Shireman J; Rosas AL; DeLay SL; Zillinger K; Geng Y; Kruger J; Silvers C; Wang H; Vazquez Cervantes GI; Hou D; Wang S; Wan H; Sonabend A; Zhang P; Lee-Chang C; Miska J
    Front Immunol; 2023; 14():1331287. PubMed ID: 38299146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial cancer cell migration: a role for chemokine receptors?
    Scotton CJ; Wilson JL; Milliken D; Stamp G; Balkwill FR
    Cancer Res; 2001 Jul; 61(13):4961-5. PubMed ID: 11431324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCR4 receptor blockage reduces the contribution of tumor and stromal cells to the metastatic growth in the liver.
    Benedicto A; Romayor I; Arteta B
    Oncol Rep; 2018 Apr; 39(4):2022-2030. PubMed ID: 29436696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expressions of CXCL16/CXCR6 and CXCL12/CXCR4 in first-trimester human trophoblast cells].
    Huang Y; Li DJ; Wang MY; Cheng HD
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):399-402. PubMed ID: 16831364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor.
    Yoon MS; Pham CT; Phan MT; Shin DJ; Jang YY; Park MH; Kim SK; Kim S; Cho D
    Cytotherapy; 2016 Dec; 18(12):1532-1542. PubMed ID: 27720639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC, CXC, and CX3C chemokines.
    Wilbanks A; Zondlo SC; Murphy K; Mak S; Soler D; Langdon P; Andrew DP; Wu L; Briskin M
    J Immunol; 2001 Apr; 166(8):5145-54. PubMed ID: 11290797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.
    MacGregor HL; Sayad A; Elia A; Wang BX; Katz SR; Shaw PA; Clarke BA; Crome SQ; Robert-Tissot C; Bernardini MQ; Nguyen LT; Ohashi PS
    J Immunother Cancer; 2019 Dec; 7(1):357. PubMed ID: 31892360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation.
    Mir H; Kaur G; Kapur N; Bae S; Lillard JW; Singh S
    Sci Rep; 2019 Feb; 9(1):2527. PubMed ID: 30792527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated macrophages promote the metastasis of ovarian carcinoma cells by enhancing CXCL16/CXCR6 expression.
    Hong L; Wang S; Li W; Wu D; Chen W
    Pathol Res Pract; 2018 Sep; 214(9):1345-1351. PubMed ID: 30049511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Cell RNA Sequencing in Lung Cancer: Revealing Phenotype Shaping of Stromal Cells in the Microenvironment.
    Zhang J; Song C; Tian Y; Yang X
    Front Immunol; 2021; 12():802080. PubMed ID: 35126365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.
    Gil M; Komorowski MP; Seshadri M; Rokita H; McGray AJ; Opyrchal M; Odunsi KO; Kozbor D
    J Immunol; 2014 Nov; 193(10):5327-37. PubMed ID: 25320277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of chemokine receptor and its ligand on migration of ovarian cancer cells].
    Li F; Zhu HS; Han ZQ; Chen G; Gao QL; Jia P; Zhang AL; Xi L; Xu Q; Liao GN; Wang SX; Lu YP; Ma D
    Ai Zheng; 2005 Jan; 24(1):23-7. PubMed ID: 15642195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational modeling of malignant ascites reveals CCL5-SDC4 interaction in the immune microenvironment of ovarian cancer.
    Kim S; Han Y; Kim SI; Lee J; Jo H; Wang W; Cho U; Park WY; Rando TA; Dhanasekaran DN; Song YS
    Mol Carcinog; 2021 May; 60(5):297-312. PubMed ID: 33721368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems.
    Katoh H; Hosono K; Ito Y; Suzuki T; Ogawa Y; Kubo H; Kamata H; Mishima T; Tamaki H; Sakagami H; Sugimoto Y; Narumiya S; Watanabe M; Majima M
    Am J Pathol; 2010 Mar; 176(3):1469-83. PubMed ID: 20110411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.